Average Co-Inventor Count = 3.75
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Leland Stanford Junior University (25 from 5,303 patents)
2. Neodyne Biosciences, Inc. (5 from 20 patents)
3. Other (4 from 832,680 patents)
4. Allergan Holdings France S.a.s. (4 from 6 patents)
5. The Johns Hopkins University (3 from 3,682 patents)
6. The United States Government As Represented by the Department of Veterans Affairs (3 from 889 patents)
7. Tautona Group Research and Development Company, L.l.c. (3 from 4 patents)
8. Tautona Group IP Holding Company, LLC (3 from 3 patents)
9. Lifecell Corporation (2 from 152 patents)
10. Albert Einstein College of Medicine (1 from 504 patents)
11. Novadaq Technologies, Inc. (1 from 30 patents)
12. Tautona Group LP (3 patents)
47 patents:
1. 12403106 - Prophylactic skin treatment for radiation therapy
2. 12303475 - Conditioning irradiated tissue for increasing vascularity
3. 12279792 - Trocar positioning apparatus and methods for use
4. 12178940 - Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation
5. 11871961 - Trocar positioning apparatus and methods for use
6. 11701262 - Devices and methods for skin tightening
7. 11690649 - Retractor apparatus and methods for use
8. 11331288 - Conditioning irradiated tissue for increasing vascularity
9. 11246763 - Skin treatment devices and methods with pre-stressed configurations
10. 11174460 - Efficient stem cell delivery into biomaterials using capillary driven encapsulation
11. 11160775 - Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
12. 11154484 - Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
13. 11013638 - Wound or skin treatment devices and methods
14. 10857037 - Controlled strain skin treatment devices and methods
15. 10751304 - Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds